Improving Batch Manufacturing Quality Review Cycle Time

Jim Cahill

Chief Blogger, Editor

Exceptions in batch manufacturing processes are the deviations that occur outside the prescribed specifications. For pharmaceutical and biopharmaceutical manufacturers, quality and manufacturing personnel must review these exceptions. Traditionally, this quality review process occurs after the batch has completed.

A recent news release, Emerson Helps Life Sciences Companies Reduce Time to Market with Faster Quality Reviews, announced enhancements to the Syncade manufacturing execution system (MES) to streamline this review-by-exception process, turning weeks into days for quality reviews.

Emerson's Kevin Stembridge


Emerson’s Kevin Stembridge, a Syncade product marketing director, noted that the Syncade Quality Review Manager application shortens the release process by simplifying and streamlining the process of accurately documenting all actions taken when responding to exceptions.

Sources of these exceptions can come from measurements and final control actions orchestrated by the DeltaV distributed control system, Syncade Workflow, or other third party systems that generate process-related exceptions.

By integrating these different data sources involved in the batch manufacturing process with a manufacturer’s exception review process, overall data integrity is improved and compliance with regulations—U.S. FDA 21 CFR Part 11 and EU Annex 11—is simplified.

Syncade Quality Review ManagerWith the Quality Review Manager, the quality department can review process exceptions as they occur and while the batch is still in process, giving a more accurate and timely response. Exception dashboards help prioritize reviews while focusing on the most critical exceptions affecting the process. After all exceptions are closed, Quality Review Manager supports an automated release method by immediately releasing finished batches once all exceptions are resolved, reducing the lag between production, product release and patient delivery.

Kevin described some of the captured exceptions such as issues detected with critical process parameters, non-standard activities (such as forced steps), comments are added to work instructions, DCS alarms and events, and manually-logged exceptions.

The Quality Review Manager user interface is based on HTML5 technology which delivers scalability and compatibility with current web browsers and most modern mobile tablet environments.

For more on Quality Review Manager and the other Syncade MES applications, visit the Manufacturing Execution Systems section on Emerson.com. You can also connect and interact with other manufacturing execution system and pharmaceutical & biotech industry experts in the Operations Management and Life Sciences groups in the Emerson Exchange 365 community.

Trackbacks/Pingbacks

  1. Moving to Electronic Batch Records - […] we highlighted advancements in exception management technology for pharmaceutical and biopharmaceutical manufacturers. Exception management is one element in an…

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Trackbacks/Pingbacks

  1. Moving to Electronic Batch Records - […] we highlighted advancements in exception management technology for pharmaceutical and biopharmaceutical manufacturers. Exception management is one element in an…

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe for Updates

Follow Us

We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.

Want to re-purpose, reuse or translate content?

Please do, Just link back to the post and send us a quick note so we can share your work. Thanks!

Our Global Community

Emerson Exchange 365

The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.